Survodutide (Boehringer Ingelheim): Targets two receptors (GLP-1 and glucagon), like a simpler version of retatrutide
A 28.3% reduction in body weight averaging 70.3 pounds lost over 80 weeks is the headline number from retatrutides TRIUMPH-1 phase 3 trial, and it lands at a moment when the obesity pharmacology field thought it had already seen its ceiling
Metabolic Boost : Some research suggests GLP-1 may increase energy expenditure, helping you burn more calories throughout the day
Not sure if your current compounding pharmacy meets these standards
News provided by Ro Aug 21, 2025, 09:00 ET The tennis icon partners with Ro to talk openly about weight, health, and the role of GLP-1 treatment NEW YORK, Aug
Want waar veel mensen spreken over afslankmedicatie alsof het een snelle oplossing is, zien we in de praktijk iets heel anders: GLP-1 medicijnen halen vooral de strijd in je hoofd weg , en maken daardoor ruimte voor echte gedragsverandering
